HBIO - Harvard Bioscience
Printed from CEF Radar (cefradar.com). Source: public filings at the U.S. Securities and Exchange Commission. Last checked: Nov 2, 2026, 1:39 a.m. New York time.
HBIO is a company, not a closed-end fund. We still track it - notices about it are below - but most of this site is about funds.
Is anyone targeting this fund?
Yes - one large investor holds a stake, but it has not asked for changes.
- Leviticus Partners LP owns 5.2% as a passive investor. On file since Sept 22, 2026.
What this means for you
One large investor owns more than 5% of this company but has told the regulator it is not seeking changes. That is common for banks, brokers and index funds that hold shares for their clients.
Nothing is required of you. If an investor changes its mind, it must file a new notice within days, and it will show up here.
What happened, and when
-
Sept 22, 2026
Leviticus Partners LP now owns 5.2%, as a passive investor.
Original document → -
April 7, 2025
Punch sold down below 5% and stopped reporting.
Original document → -
Feb 14, 2024
Punch now owns 6.8%, as a passive investor.
Original document →
Details: all notices, events and fund facts
| Date | Investor | Stake | Type of notice |
|---|---|---|---|
| Sept 22, 2026 | Leviticus Partners LP | 5.2% | Updated notice |
| April 7, 2025 | Punch | 0.1% | Sold down below 5% |
| Feb 14, 2024 | Punch | 6.8% | Updated notice |
No announcements from the fund on file. Most funds announce their payout on their own website, not in a filing with the regulator, so a cut or a raise there does not show up here.
- Run by
- not filed yet
- Fund family
- not filed yet
- Exchange
- Nasdaq
See this fund's page at the SEC →
Email me when something new is filed for HBIO
Free. One email when a large investor files a notice, or when the fund announces a buy-back, a vote or a closing - usually within a day. No password. Most funds announce payout changes on their own website, where we do not look.